This inventor holds 1 USPTO granted patent. Top assignees: China Fortune Way Company, Nanjing Redwood Fine Chemical Co., Ltd.. Active years: 2022.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2022
Title: Yangzhe Gao: Innovator in Biocatalytic Synthesis
Introduction
Yangzhe Gao is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biocatalysis, particularly in the synthesis of pharmaceutical compounds. His innovative approach has led to advancements in the production of important medications.
Latest Patents
Yangzhe Gao holds a patent for a method for biocatalytic synthesis of Sitagliptin and its intermediates. This patent outlines a process that involves compounds of Formula (I) and Formula (II), along with a polypeptide that catalyzes the conversion of these compounds. The patent also includes details about a nucleic acid encoding the polypeptide, a vector, and a cell that contains the nucleic acid. This method enhances the efficiency of producing Sitagliptin, a medication used to treat type 2 diabetes.
Career Highlights
Throughout his career, Yangzhe Gao has worked with several companies, including China Fortune Way Company and Nanjing Redwood Fine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in chemical synthesis and biocatalysis.
Collaborations
Yangzhe Gao has collaborated with notable colleagues such as Lili Liu and Wen Wen Yang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yangzhe Gao's contributions to biocatalytic synthesis represent a significant advancement in pharmaceutical development. His work continues to impact the field positively, showcasing the importance of innovation in medicine.